Exploratory secondary analysis of an RCT in 140 pregnant adults with OUD: in the 73 with depression/anxiety symptoms, extended-release injectable vs sublingual buprenorphine showed higher abstinence in pregnancy (difference 12.5%, p=0.03), vs 6.7% (p=0.27) without.
Secondary analysisn = 140
Cochran et al. Extended-release injection vs sublingual buprenorphine for illicit opioid use in pregnant patients with depression and/or anxiety